Personalized Medicine · For When Nothing Else Works

The right drug. The right person. Even if it doesn’t exist yet.

We work alongside hospitals to deliver personalized medicine — selecting the best existing drug for each patient, or creating a new one from scratch when nothing else works. What used to take 10–15 years, we do in hours.

Hours
Drug selection time
1 week
To personalized clinical trial
800M+
Patients with no options left
The problem

When every option fails, the system has no answer

Current personalized medicine is built on statistics, not biology. It forgets the molecular rules that govern disease. And when every approved treatment has failed, there is simply nothing left to try.

Medicine by Statistics, Not Biology

Today’s drug selection is based on population averages — not on what is happening inside your cells. Real biology is ignored, and patients pay the price.

Not personalized — generalized

No Drug, No Hope

When all approved treatments have failed a patient, the pipeline ends. There is no extra drug. No final option. No last resort.

Nothing left for millions

10–15 Years Too Late

Creating a new therapy takes over a decade and costs up to $2 billion. By the time it reaches the patient who needed it, it is already too late.

10–15 years to market
Our approach

We study your biology. Then we act on it.

From a single biopsy, our AI — grounded in real biological rules, not statistics — understands the disease at a molecular level. Then our technology finds or creates the solution.

Virtual Bio Lab Software — Digital Cell Twin dashboard
Live dashboard — Virtual Bio Lab v2.9
AI Software

Biological Intelligence

From a biopsy sample, our AI builds a molecular map of the patient’s disease. No statistics. No black boxes. Pure biology. We then prioritize from all approved drugs what will work best for that specific patient.

  • Molecular-level disease understanding from biopsy
  • AI grounded in biological rules, not statistics
  • Approved drug prioritization for each patient
  • Drug-gene interaction prediction
Explore Software →
Lab On A Cell — massively parallel cell array hardware
Lab On A Cell — patentable technology
Lab Hardware

Lab On A Cell

When no approved drug works, we create one. We’ve found a way to fit an entire traditional laboratory inside a single living cell. All molecular and toxicology assays now happen in microns — preclinical data and GMP certifications from a device on your table.

  • Whole laboratory inside a single living cell
  • All preclinical assays in microns of space
  • GMP-ready tabletop device
  • Thousands of candidates tested in parallel
Explore Hardware →

When there is nothing else to do, there will still be something else to do. There will be Ajax.

From hospital admission to personalized clinical trial — in one week

This is what it looks like when biology, AI, and a cell-sized laboratory work together for one patient.

In no time, at almost no cost, we treat patients one by one

1

Understand the Disease

A biopsy sample arrives at our platform. Our AI — grounded in biological rules, not statistics — maps the disease at a molecular level. We understand what’s broken, why, and what can fix it.

→ Hours, not months
2

Find or Create the Drug

We prioritize from all approved drugs what will work best. If nothing on the list works, we design new therapeutic candidates. Not hypotheticals — real, testable molecules.

→ From approved drugs to novel solutions
3

Test, Certify, Treat

Our Lab On A Cell runs all preclinical assays and toxicology tests in parallel — thousands of candidates in microns of space. One week after admission, the patient begins a personalized clinical trial.

→ 1 week to clinical trial
Digital Twin Engine
// Patient digital twin: disease pathway simulation
function buildPatientTwin(patientId) {
  var genomics = getPatientGenome(patientId);
  var proteomics = getProteomics(patientId);
  var twin = createDigitalTwin(genomics, proteomics);
  return twin.simulateDisease();
}

// Personalized drug screening
function screenTherapies(twin) {
  var candidates = generateCandidates(twin.targets);
  var results = simulateEfficacy(candidates, twin);
  return results.rankByResponse();
}

// Drug-gene interaction prediction
function predictInteractions(drug, patient) {
  var pathways = mapDrugTargets(drug);
  var risk = assessAdverseEffects(pathways, patient);
  if (risk.score < 0.05) {
    return approveForTrial(drug);
  }
}

// Cellular teleprogramming: on-demand manufacturing
function manufactureTherapy(approvedDrug) {
  var cells = programCells(approvedDrug.sequence);
  return cells.produceAtBedside();
}

Biological Intelligence
Molecular Disease Mapping
Approved Drug Prioritization
Novel Candidate Design
Drug-Gene Interaction Prediction
Lab On A Cell Technology
Lab On A Cell Platform
GMP-ready Tabletop Device
Partners, Accelerators & Institutions

The ecosystem that backs AjaxDNA

Lanzadera Lanzadera
IDEAS UPV IDEAS UPV
AgrotecUV AgrotecUV
Bioval Bioval
Food for Life-Spain · Plataforma Tecnológica Española Food for Life
Universitat Politècnica de València UPV
ENISA — Empresa Emergente Certificada ENISA
IBV — Entidad Asociada IBV
València Innovation Capital VLC Innovation Capital

Awards & Programs

Recognition from the ecosystem and leading acceleration programs backing AjaxDNA.

Premios Ingenia Startup 2025 — Alejandro Atienza on TVE2
FIAB · Food for Life-Spain 08.09.2025 Award

Premios Ingenia Startup 2025 — AjaxDNA named one of 3 winning startups (7ª Ed.)

Finalist competing for Gold at Alibetopías 2025 · Oct 21
Premios Paterna Ciudad de Empresas 2025 ceremony
Premios Paterna Ciudad de Empresas 12.2024 Award

Best Startup — Premios Paterna Ciudad de Empresas 2024

Paterna City · Best Startup Prize
BioLynx Innovation Competition — AJAX winning team
BioLynx · Fundación DRO 30.03.2025 Award

Competición de Innovación Abierta — Ajax Winner in Sustainability category

BioLynx Community · Fundación DRO
Talento Joven Levante-CaixaBank press
Levante-EMV · CaixaBank 02.2025 Award

XII Premios Talento Joven — Alejandro Atienza finalist in Business category

Levante-EMV · CaixaBank · CaixaForum València
Valencia Innovation Capital 2025 — grant ceremony
València Innovation Capital 2025 Grant

Premios de Innovación València Innovation Capital 2025 — Gemelos Digitales Biológicos

Ajax Biosciences S.L. · València Innovation Capital

Press & Coverage

Our growing footprint in global media and biotech ecosystems.

Valencia Digital Summit 2025 panel
Valencia Digital Summit 10.2025 Event

Alejandro Atienza participates in panel discussion at Valencia Digital Summit 2025 (#VDS2025)

VDS · City of Arts and Sciences · Valencia
FuckUp Nights — Cátedra de Cultura Empresarial UV
Cátedra de Cultura Empresarial · UV 2024 Event

FuckUp Nights — Alejandro Atienza shares entrepreneurial lessons at Cátedra de Cultura Empresarial

Cátedra de Cultura Empresarial · Universitat de València
La Bombilla de Livermore Ep.15 — Alejandro Atienza (Ajax DNA)
Parc Científic UV · Podcast 12.2024 Podcast

La Bombilla de Livermore Ep.15 — Alejandro Atienza (Ajax DNA) en el podcast oficial del PCUV

Podcast PCUV · Parc Científic Universitat de València

Your patients are out of options. We’re not.

Talk to us about how AjaxDNA can help your hospital deliver personalized medicine — from drug selection to personalized clinical trials — in days, not decades.

01

Clinical Assessment

We evaluate your patient’s case and show you what our platform can do for them.

02

Platform Demo

See how a biopsy becomes a molecular disease map, a drug selection, and a treatment plan.

03

Hospital Integration

We design a deployment plan that fits your clinical infrastructure and regulatory requirements.

Get Started Today